Liver disease in Viet Nam: Screening, surveillance, management and education: A 5-year plan and call to action

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 2, 2012, Pages 238-247

  Gish, Robert G ^a   Bui, Tam D ^b   Nguyen, Chuc T K ^e   Nguyen, Duc T ^c   Tran, Huy V ^f   Tran, Diem M T ^f   Trinh, Huy N ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Internal Medicine   (United States)

^c NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^d San Jose Gastroenterology   (United States)

^e HANOI MEDICAL UNIVERSITY   (Viet Nam)

^f HUE UNIVERSITY   (Viet Nam)

Author keywords

Alcoholic liver disease; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Vietnam

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS C VACCINE;

ALCOHOL LIVER DISEASE; ARTICLE; CANCER EPIDEMIOLOGY; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH EDUCATOR; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; MEDICAL CARE; MORBIDITY; MORTALITY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; VERTICAL TRANSMISSION; VIET NAM;

EID: 84856135763     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06974.x     Document Type: Article

References (40)

1. Tran HT, Ushijima H, Quang VX etal. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol. Res. 2003; 26: 275-80.
2. Nakata S, Song P, Duc DD etal. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J. Gastroenterol. Hepatol. 1994; 9: 416-19.
3. Hipgrave DB, Nguyen TV, Vu MH etal. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am. J. Trop. Med. Hyg. 2003; 69: 288-94.
4. Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J. Gastroenterol. Hepatol. 2007; 22: 2093-100.
5. Bich TH, Nga PT, Quang LN etal. Patterns of alcohol consumption in diverse rural populations in the Asian region. Glob. Health Action 2009; 2: doi: 10.3402/gha.v2i0.2017.
6. Ngoan LT, Lua NT, Hang LTM. Cancer mortality pattern in Viet Nam. Asian Pac. J. Cancer Prev. 2007; 8: 535-8.
7. Nguyen VT, Law MG, Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int. 2008; 28: 525-31.
8. Nguyen HD, Le NT, Nguyen CD etal. International epidemiological collaborative surveillance, epidemiology and prevention of HBV, HCV, HIV and rabies in the greater Mekong sub-region. Hanoi Medical University. 2010. Cited 3 December 2011. Available from URL:.
9. Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac. J. Cancer Prev. 2009; 10: 97-102.
10. Kakumu S, Sato K, Morishita T etal. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam. J. Med. Virol. 1998; 54: 243-8.
11. de Jongh FE, Janssen HL, De Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen- positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-5.
12. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2000; 15 (Suppl.): E25-30.
13. de Franchis R, Meucci G, Vecchi M etal. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann. Intern. Med. 1993; 118: 191-4.
14. Fattovich G, Brollo L, Giustina G etal. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-8.
15. Lok AS. Natural history and control of perinatally acquired hepatitis B virus infection. Dig. Dis. 1992; 10: 46-52.
16. Mohamed R, Desmond P, Suh DJ etal. Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J. Gastroenterol. Hepatol. 2004; 19: 958-69.
17. Murakami H, Van Cuong N, Huynh L, Hipgrave DB. Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam. Vaccine 2008; 26: 1411-19.
18. Quan VM, Go VF, Nam LV etal. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care 2009; 21: 7-16.
19. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 2003; 327: 1075.
20. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull. World Health Organ. 1999; 77: 789-800.
21. Nguyen VT, McLaws ML, Dore GJ. Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol. Int. 2007; 1: 387-93.
22. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26: 15S-20S.
23. Cordier S, Le TB, Verger P etal. Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam. Int. J. Cancer 1993; 55: 196-201.
24. Huy TV. Markers of HBV and HCV in patients with hepatocellular carcinoma in Vietnam. APASL. Kyoto, Japan. 2007. P-0576.
25. Ngoc NB, Lien NB, Huong NL. Human resource for health in Vietnam and mobilization of medical doctors to commune health centers. 1-13. Asia-Pacific Action Alliance on Human Resources for Health. 2005. Cited 5 December 2011. Available from URL:.
26. Tuan T, Dung VT, Neu I, Dibley MJ. Comparative quality of private and public health services in rural Vietnam. Health Policy Plan. 2005; 20: 319-27.
27. Henderson DK, Dembry L, Fishman NO etal. Society for Healthcare Epidemiology of America. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect. Control Hosp. Epidemiol. 2010; 31: 203-32.
28. WHO (World Health Organization). WHO in Vietnam: blood safety. WHO. WHO. 3-10-2010. 2010. Cited 5 December 2011. Available from URL:.
29. Clatts MC, Colon-Lopez V, Giang LM, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J. Urban Health 2010; 87: 278-91.
30. Quan VM, Chung A, Abdul-Quader AS. The feasibility of a syringe-needle-exchange program in Vietnam. Subst. Use Misuse 1998; 33: 1055-67.
31. Pham HT, Chu TV, Nguyen HT etal. Ensuring effectiveness of a community-based outreach program for injection drug users. 15th International Conference on AIDS. Bangkok, Thailand. 2004. Abstract-2173581 Cited 5 December 2011. Available from URL:.
32. Ngo AD, Schmich L, Higgs P, Fischer A. Qualitative evaluation of a peer-based needle syringe programme in Vietnam. Int. J. Drug Policy 2009; 20: 179-82.
33. IHRD (International Harm Reduction Development Program). Harm reduction developments 2008: countries with injection-driven HIV epidemics. New York, New York, Open Society Institute. 2008. Cited 5 December 2011. Available from URL:.
34. United States Department of State. Background note: Vietnam. US Department of State. 2009. 3-12-2010. Cited 5 December 2011. Available from URL:.
35. Murray CJ, Lopez A. World Health Report 2002: reducing Risks, Promoting Healthy Life. Geneva, Switzerland, World Health Organization. 2002. Cited 5 December 2011. Available from URL:.
36. Beutels P. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). Health Econ. 2001; 10: 751-74.
37. Aggarwal R, Ghoshal UC, Naik SR. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J. Hepatol. 2003; 38: 215-22.
38. Hutton DW, So SK, Brandeau ML. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology 2010; 51: 405-14.
39. Dziekan G, Chisholm D, Johns B, Rovira J, Hutin YJ. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings. Bull. World Health Organ. 2003; 81: 277-85.
40. Miller MA, Pisani E. The cost of unsafe injections. Bull. World Health Organ. 1999; 77: 808-11.